Epigenomic regulation in skeletal muscle cells and their precursors
Epigenomic regulation in skeletal muscle cells and their precursors
批准号:
9174484
负责人:
Brian D Dynlacht
金额:
$22.37万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-01 至 2018-03-31
关键词:
AddressAgeAnimalsAreaBasal laminaBindingBiochemicalBiologicalBiologyCardiac MyocytesCell MaintenanceCell modelCellsCellular biologyChIP-seqCharacteristicsChemicalsChromatinClinicalCoculture TechniquesConditioned Culture MediaDataData SetDiseaseEctopic ExpressionEnhancersEpigenetic ProcessExhibitsGene ExpressionGene Expression ProfileGene SilencingGenesGenomicsGoalsHeterogeneityIn VitroLightMaintenanceMapsMesenchymalMesenchymal Stem CellsMethodsMicroRNAsModelingModificationMolecularMolecular ProfilingMusMuscleMuscle CellsMuscle FibersMuscle satellite cellMuscular AtrophyMyoblastsMyogenic Regulatory FactorsMyopathyNatural regenerationPericytesPopulationPositioning AttributePropertyProteinsProtocols documentationRefractoryRegulationRegulator GenesRegulatory ElementRoleSarcolemmaSkeletal MuscleSkeletal Muscle Satellite CellsSourceSpecific qualifier valueStem cellsStudy modelsTestingTherapeuticTimeTimeLineTissuesTranslationsTransplantationabstractingcell typecellular engineeringchromatin remodelingembryonic stem cellepigenomeepigenomicsgenetic manipulationgenome-widegenome-wide analysishuman embryonic stem cellimprovedin vivoinsightmuscle regenerationnovelpluripotencyregenerativesatellite cellskeletal muscle differentiationstemnesstranscription factortranscriptometranscriptome sequencingtranscriptomics
中文摘要
项目摘要
卫星细胞是位于肌肉基板和肌膜之间的肌肉干细胞。
纤维,它们就像一个池,再生受损的肌肉组织。而胚胎
干细胞已经在转录和表观遗传水平上得到了广泛的表征,我们的
对卫星细胞的了解还很初级。尽管干细胞对肌肉再生是必不可少的,但它们
事实证明,由于一些技术障碍,包括它们在
肌肉组织,ES细胞不能分化为骨骼肌,SC不能维持
文化中的“茎”。最近,我们已经开始描述一种新的卫星细胞模型-iPax7细胞-在
Pax7是卫星细胞识别的主要调控因子,在ES细胞中可诱导表达。IPax7细胞有
已经被证明可以重新填充动物的卫星细胞生态位,但它们还没有在
分子或基因组水平。
我们的目标是:首先,我们将更深入地描述用于卫星电池的新型iPax7。
第二,我们将首次尝试获得卫星细胞特异的基因表达特征。我们会
确定SC的标记,这将对了解和表征卫星细胞和
其他肌源性前体细胞。第三,我们将揭开Pax7,一个规范和要求的主监管机构
维护SC身份,集合关键的监管要素。这将使我们能够设计出一种基因
卫星细胞的调控网络或蓝图,让我们了解Pax7是如何控制
其他指定干细胞身份的转录因子。我们将利用我们最近获得的表观遗传学数据
和Pax7芯片序列数据,以及我们绘制成肌细胞基因组图谱的丰富数据集和
肌管,追求两个特定的目标。在目标1中,我们将比较iPax7细胞和肌肉来源的卫星
用全基因组表观遗传学和转录组水平比较细胞和ES细胞。这些研究将
使我们能够识别卫星细胞特有的特征。我们将检验一组转录的假设
FACTS与Pax7合作决定卫星小区的身份。在目标2中,我们将研究Pax7在
通过解剖肌源性前体和SC在调控中的作用来调节其表观组学格局
元素。我们的研究将为全面理解转录因子奠定重要基础。
伴随着从多能性到骨骼肌身份的限制而产生的网络和表观基因组变化。
此外,这些研究可能揭示Pax7在卫星细胞维持中的重要机制作用
知之甚少的地区。了解和利用这些肌源性前体,可以在
Will可能在临床环境中被证明是无价的,为提高其再生能力开辟了新的途径
并为治疗肌肉萎缩和疾病提供了可能的治疗机会。
英文摘要
Project Abstract
Satellite cells (SC) are muscle stem cells positioned between the basal lamina and the sarcolemma of muscle
fibers, and they serve as a pool to regenerate muscle tissue that has been damaged. Whereas embryonic
stem (ES) cells have been extensively characterized at the transcriptional and epigenetic levels, our
understanding of satellite cells is rudimentary. Although SC are essential for muscle regeneration, they have
proven refractory to characterization owing to a number of technical impediments, including their paucity in
muscle tissue, the inability of ES cells to differentiate into skeletal muscle, and the inability of SC to maintain
“stemness” in culture. Recently, we have begun characterizing a novel satellite cell model—iPax7 cells--in
which the master regulator of satellite cell identity, Pax7, is inducibly expressed in ES cells. iPax7 cells have
been shown to repopulate the satellite cell niche in animals, but they have not been characterized at the
molecular or genomic level.
Our goals are as follows. First, we will more deeply characterize the novel iPax7 model for satellite cells.
Second, we will for the first time attempt to obtain a satellite cell-specific gene expression signature. We will
identify markers of SC, which will be of further value for understanding and characterizing satellite cells and
other myogenic precursors. Third, we will unravel how Pax7, a master regulator required for specification and
maintenance of SC identity, assembles key regulatory elements. This will enable us to devise a gene
regulatory network or “blueprint” for satellite cells, allowing us to understand how Pax7 controls expression of
other transcription factors that specify stem cell identity. We will leverage our recently acquired epigenetic data
and Pax7 ChIP-seq data, as well as our rich data set mapping the genomic landscape of myoblasts and
myotubes, to pursue two Specific Aims. In Aim 1, we will compare iPax7 cells with muscle-derived satellite
cells and ES cells using genome-wide epigenetic and transcriptome-level comparisons. These studies will
allow us to identify satellite cell-specific signatures. We will test the hypothesis that a set of transcription
factors collaborates with Pax7 to dictate satellite cell identity. In Aim 2, we will examine the role of Pax7 in
modulating the epigenomic landscape of myogenic precursors and SC by dissecting its role at regulatory
elements. Our studies will lay important groundwork for a comprehensive understanding of the transcriptional
networks and epigenomic changes that accompany the restriction from pluripotency to skeletal muscle identity.
Additionally, these studies may reveal essential mechanistic roles for Pax7 in satellite cell maintenance, a
poorly understood area. Understanding and utilizing these myogenic precursors, which can be manipulated at
will, may prove invaluable in a clinical setting, opening novel avenues to improve their regenerative capacity
and suggesting possible therapeutic opportunities for treatment of muscle wasting and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tubulin modifications and cytoskeletal alterations in aging
-
批准号:10590128
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2023
-
负责人:Brian D Dynlacht
-
依托单位:
Exploring networks underlying muscle stem cell identity - Resubmission - 1
-
批准号:10627924
-
项目类别:
-
资助金额:$46.48万
-
财政年份:2021
-
负责人:Brian D Dynlacht
-
依托单位:
Exploring networks underlying muscle stem cell identity - Resubmission - 1
-
批准号:10406897
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2021
-
负责人:Brian D Dynlacht
-
依托单位:
Exploring networks underlying muscle stem cell identity - Resubmission - 1
-
批准号:10116803
-
项目类别:
-
资助金额:$48.17万
-
财政年份:2021
-
负责人:Brian D Dynlacht
-
依托单位:
Restoring ciliogenesis as a novel approach to blocking breast cancer growth
-
批准号:9292934
-
项目类别:
-
资助金额:$19.66万
-
财政年份:2017
-
负责人:Brian D Dynlacht
-
依托单位:
Regulation of myogenic transcription by the Paf1C complex
-
批准号:9537650
-
项目类别:
-
资助金额:$41.77万
-
财政年份:2017
-
负责人:Brian D Dynlacht
-
依托单位:
pRB and changes in the chromatin landscape during myogenic differentiation
-
批准号:8665617
-
项目类别:
-
资助金额:$9.37万
-
财政年份:2014
-
负责人:Brian D Dynlacht
-
依托单位:
The Role of pRB and Co-repressors in Transcriptional Regulation
-
批准号:8764196
-
项目类别:
-
资助金额:$10.14万
-
财政年份:2013
-
负责人:Brian D Dynlacht
-
依托单位:
The Role of pRB and Co-repressors in Transcriptional Regulation
-
批准号:8761281
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2013
-
负责人:Brian D Dynlacht
-
依托单位:
The Role of CP110 in Ciliogenesis
-
批准号:8663546
-
项目类别:
-
资助金额:$16.78万
-
财政年份:2013
-
负责人:Brian D Dynlacht
-
依托单位:
Elucidating the regulators of ciliogenesis - Diversity Supplement
-
批准号:10818876
-
项目类别:
-
资助金额:$10.25万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
The Role of CP110 in Ciliogenesis
-
批准号:8474814
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
The Role of CP110 in Ciliogenesis
-
批准号:8324678
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
Elucidating the regulators of ciliogenesis
-
批准号:10165741
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
Elucidating the regulators of ciliogenesis
-
批准号:10467077
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
The Role of CP110 in Ciliogenesis
-
批准号:8160343
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
Elucidating the regulators of ciliogenesis - Revision - Equipment Supplement
-
批准号:10797805
-
项目类别:
-
资助金额:$20.98万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
Elucidating the regulators of ciliogenesis
-
批准号:10650768
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
Elucidating the regulators of ciliogenesis
-
批准号:10440318
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2011
-
负责人:Brian D Dynlacht
-
依托单位:
Role of the pRB family in Quiescence and Differentiation
-
批准号:7812624
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2009
-
负责人:Brian D Dynlacht
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: